Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis

The prognostic value of two antibodies targeting citrullinated antigens, anti-Sa and anti-cyclic citrullinated peptide (CCP), present at inclusion, was evaluated prospectively in a cohort of 165 consecutive patients with recent-onset or early polyarthritis (EPA) followed for up to 30 months. Patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Boire, Gilles, Cossette, Pierre, de Brum-Fernandes, Artur J, Liang, Patrick, Niyonsenga, Théophile, Zhou, Zhijie J, Carrier, Nathalie, Daniel, Claude, Ménard, Henri-A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1174957/
https://www.ncbi.nlm.nih.gov/pubmed/15899046
http://dx.doi.org/10.1186/ar1719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1174957/
https://www.ncbi.nlm.nih.gov/pubmed/15899046
http://dx.doi.org/10.1186/ar1719

Ejemplares similares